Drug therapy: antiplatelet therapy (second of two parts).

Bronchodilator therapy (second of two parts).

Drug therapy. Drug allergy (second of three parts).

Vasodilator therapy of cardiac failure (second of two parts).

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Gastrin (second of two parts).

Histamine (second of two parts).

Lung defense mechanisms (second of two parts).

Renal transplantation (second of two parts).

Duration of dual antiplatelet therapy after drug-eluting stents.


Clinical pharmacokinetics (second of two parts).

Polymyositis and dermatomyositis (second of two parts).





Dialytic therapy for irreversible uremia (first of two parts).

Dual antiplatelet therapy duration after drug-eluting stents: how long?

Pharmacogenetics of antiplatelet therapy.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Concerning antiplatelet therapy.

Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.

Antiplatelet therapy and cataract surgery.

Clinical pharmacology of oral antidiabetic agents (second of two parts).

Suggest Documents

Bronchodilator therapy (second of two parts).

Drug therapy. Drug allergy (second of three parts).

Vasodilator therapy of cardiac failure (second of two parts).

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Gastrin (second of two parts).

Histamine (second of two parts).

Lung defense mechanisms (second of two parts).

Renal transplantation (second of two parts).

Duration of dual antiplatelet therapy after drug-eluting stents.

Duration of dual antiplatelet therapy after drug-eluting stents.

Clinical pharmacokinetics (second of two parts).

Polymyositis and dermatomyositis (second of two parts).

Duration of dual antiplatelet therapy after drug-eluting stents.

Duration of dual antiplatelet therapy after drug-eluting stents.

Duration of dual antiplatelet therapy after drug-eluting stents.

Duration of dual antiplatelet therapy after drug-eluting stents.

Dialytic therapy for irreversible uremia (first of two parts).

Dual antiplatelet therapy duration after drug-eluting stents: how long?

Pharmacogenetics of antiplatelet therapy.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Concerning antiplatelet therapy.

Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.

Antiplatelet therapy and cataract surgery.

Clinical pharmacology of oral antidiabetic agents (second of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

Recommend Documents

Follow Us